GB0307366D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0307366D0
GB0307366D0 GB0307366A GB0307366A GB0307366D0 GB 0307366 D0 GB0307366 D0 GB 0307366D0 GB 0307366 A GB0307366 A GB 0307366A GB 0307366 A GB0307366 A GB 0307366A GB 0307366 D0 GB0307366 D0 GB 0307366D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0307366A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Priority to GB0307366A priority Critical patent/GB0307366D0/en
Publication of GB0307366D0 publication Critical patent/GB0307366D0/en
Priority to PCT/GB2004/001367 priority patent/WO2004087124A1/en
Priority to US10/551,138 priority patent/US20060199978A1/en
Priority to JP2006506051A priority patent/JP2006525980A/en
Priority to EP04724064A priority patent/EP1608354A1/en
Ceased legal-status Critical Current

Links

GB0307366A 2003-03-29 2003-03-29 Compounds Ceased GB0307366D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0307366A GB0307366D0 (en) 2003-03-29 2003-03-29 Compounds
PCT/GB2004/001367 WO2004087124A1 (en) 2003-03-29 2004-03-29 Compounds having serotonin 5-ht17 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
US10/551,138 US20060199978A1 (en) 2003-03-29 2004-03-29 Compounds having serotonin 5-ht17 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
JP2006506051A JP2006525980A (en) 2003-03-29 2004-03-29 Compounds having serotonin 5-HT17 receptor antagonist activity and muscarinic M4 receptor agonist activity and their use in the treatment of psychosis
EP04724064A EP1608354A1 (en) 2003-03-29 2004-03-29 Compounds having serotonin 5-ht7 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0307366A GB0307366D0 (en) 2003-03-29 2003-03-29 Compounds

Publications (1)

Publication Number Publication Date
GB0307366D0 true GB0307366D0 (en) 2003-05-07

Family

ID=9955853

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0307366A Ceased GB0307366D0 (en) 2003-03-29 2003-03-29 Compounds

Country Status (1)

Country Link
GB (1) GB0307366D0 (en)

Similar Documents

Publication Publication Date Title
GB0309781D0 (en) Compounds
GB0316915D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0304665D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1658301A4 (en) N-desmethyl-n-substituted-11-deoxyerythromycin compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0302512D0 (en) Compounds
GB0304494D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0307998D0 (en) Compounds
GB0310067D0 (en) Compounds
GB0314477D0 (en) Compounds
GB0302543D0 (en) Compounds
GB0304493D0 (en) Compounds
GB0301916D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)